Brind.

Innate Pharma developed an mAb with AstraZeneca and is a trusted partner to Sanofi, with BTIG initiating analyst coverage.

2 reports, 2 independent Updated Aug 14

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Innate Pharma developed an mAb with AstraZeneca and is a trusted partner to Sanofi, with BTIG initiating analyst coverage.

Who's involved

What this event is mainly about

AstraZeneca Sanofi

Keep exploring

The entities involved

AstraZeneca
British-Swedish pharmaceutical company
- Analyst reports are driving stock market sentiment for Ballard Power Systems, AstraZeneca, Amgen, and Amazon.Wed 14:51
- Dan Janiak joined OncoC4 as Chief Business Officer, having previously served at AstraZeneca.Mon 13:33
Sanofi
company in Milan, Italy
- Sanofi advances Kymera's degrader candidate.Wed 19:26

Coverage

Newest first; wire copies grouped

Aug 14finanznachrichten.de
Jul 29Business WireInnate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference MARSEILLE, France, July 29, 2025--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasda